N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk

Pharmacogenetics

Volumn 8, Issue 4, 1998, Pages 291-298

  Bouchardy, Christine ^a   Mitrunen, Katja ^b   Wikman, Harriet ^b   Husgafvel Pursiainen, Kirsti ^b   Dayer, Pierre ^c   Benhamou, Simone ^d   Hirvonen, Ari ^b  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Lung cancer; N acetyltransferase; NAT1; NAT2

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; CARCINOGEN; XENOBIOTIC AGENT;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ACETYLTRANSFERASES; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENOTYPE; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TUMOR MARKERS, BIOLOGICAL;

NICOTIANA TABACUM;

EID: 0031824377     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199808000-00002     Document Type: Article

References (27)

1. Badawi AF, Hirvonen A, Bell DA, Lang NT, Kadlubar FF. Role of aromatic amine acetyltransferases: NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 1995; 55:5230-5237.
2. Baker RJ, Nelder JA. Generalized linear interactive modelling (GLIM) system. Release 3. Oxford; Numerical Algorithms Group; 1978.
3. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993; 14:1689-1692.
4. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadluhar FF, Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polydenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissues. Cancer Res 1995a; 55:5226-5229.
5. Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of the colorectal cancer. Cancer Res 1995b; 55:3537-3542.
6. Bouchardy C, Benhamou S, Dayer P. The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 1996; 56:251-253.
7. Breslow NE, Day NE. The analysis of case-control studies. In: Statistical Methods in Cancer Research. IARC Scientific Publications, vol. 1, no. 32. Lyon: France: International Agency for Research on Cancer; 1980, pp. 192-242.
8. Burgess EJ, Trafford JAP. Acetylator phenotype in patients with lung carcinoma - a negative report. Eur J Resp Dis 1985; 67:17-19.
9. Cascorbi I, Drakoulis N, Brockmöller J, Mauer A, Sperling K, Roots I. Arylamine N-acetyltransferase (NAT2) mutation and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am J Hum Genet 1995; 57:581-592.
10. Cascorbi I, Brockmöller J, Mrozikiewicz PM, Bauer S, Loddenkemper R, Roots I. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer. Cancer Res 1996; 56:3961-3966.
11. Deitz AC, Doll MA, Hein DW. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles. Anal Biochem 1997; 253:219-224.
12. Doll MA, Jiang W, Deitz AC, Rustan TD, Hein DW. Identification of a novel allele at the human NAT1 acetyltransferase locus. Biochem Biophys Res Commun 1997; 233:584-591.
13. d'Errico A, Taioli E, Chen X, Vineis P. Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers 1996; 1:149-173.
14. Evans DAP. N-acelyltransferase. Pharmacol Ther 1989; 42:157-234.
15. Frederickson SM, Messing EM, Reznikoff CA, Swaminathan S. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol Biomarkers Prev 1994; 3:25-32.
16. GLIM. The generalised linear interactive modelling sytsem. 2nd ed. Payne CD (editor). Oxford: The Nuffield Press Ltd: 1987.
17. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, et al. Human acetyltransferase polymorphisms. Mutat Res 1997; 376:61-70.
18. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, et al. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and NAT2 acetyltransferases. Carcinogenesis 1993; 14:1633-1638.
19. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NO. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 1992; 98:69-74.
20. Ladero JM, Jara C, Benitez J, Fernandez MJ, Vargas E, Munoz JJ, et al. Polimorfismo acetilador en el cancer de pulmon. An Med Intern 1991; 2:66-68.
21. Martinez C, Agùndez JA, Olivera M, Martin R, Ladero JM, Benitez J. Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics 1995; 5:207-214.
22. Philip PA, Fitzgerald DL, Cartwright RA, Peake MD, Rogers HJ. Polymorphic N-acetylation capacity in lung cancer. Carcinogenesis 1988; 9:491-493.
23. Probst M, Blum M, Fasshauer I, D'Orazio D, Meyer U, Wild D. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-Latin small letter esh sign]quinoline (IQ). Carcinogenesis 1992; 13:1713-1717.
24. Probst-Hensch NM, Haile RW, Li DS, Sakamoto GT, Louie D, Lin BK, et al. Lack of association between the polyadenylation polymorphism in NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis 1996; 17:2125-2129.
25. Roots I, Drakoulis N, Ploch M, Heinemeyer G, Loddenkemper R, Minks T, et al. Debrisoquine hydroxylation phenotype: acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Klin Wochenschr 1988; 66:87-97.
26. Vatsis KP, Weber WW. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch Biochem Biophys 1995; 1:71-76.
27. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 1994; 369:154-156.